Clinical trial

Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)

NCT03454750

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-10-25

PhasePHASE2

Study timeline

Study start (actual)2022-10-25Date precision: day

Registry last updated2025-01-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Castration Resistant Prostate Cancerunresolved

68Ga-PSMA PET/CT Positiveunresolved

Interventions

177Lu-PSMADRUG

Sponsors & collaborators

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03454750 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.